Showing results (151-160 of 259) with videos related to

Sort By:
Pageof 26
Clinical Therapeutics|October 4, 2005
A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged > or =65 years with community-acquired pneumoniaAndrew F Shorr, Neringa Zadeikis, Jim X Xiang, et al.
Medicine|September 12, 2018
Hospital readmission with Clostridium difficile infection as a secondary diagnosis is associated with worsened outcomes and greater revenue loss relative to principal diagnosis: A retrospective cohort studyMarya D Zilberberg, Brian H Nathanson, Stephen Marcella, et al.
Journal of Critical Care|April 24, 2012
Predicting the need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: comparing the CURB-65 and BAP-65 scoresAndrew F Shorr, Xiaowu Sun, Richard S Johannes, et al.
BMC Pulmonary Medicine|August 28, 2010
Imipenem resistance of Pseudomonas in pneumonia: a systematic literature reviewMarya D Zilberberg, Joyce Chen, Samir H Mody, et al.
Critical Care (London, England)|March 2, 2013
Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patientsAndrew A Udy, Jason A Roberts, Andrew F Shorr, et al.
Critical Care Medicine|September 9, 2005
Fluconazole prophylaxis in critically ill surgical patients: a meta-analysisAndrew F Shorr, Kevin Chung, William L Jackson, et al.
Chest|May 13, 2005
Transfusion practice and blood stream infections in critically ill patientsAndrew F Shorr, William L Jackson, Kathleen M Kelly, et al.
Critical Care (London, England)|February 27, 2008
The protein C pathway: implications for the design of the RESPOND studyBurkhard Vangerow, Andrew F Shorr, Duncan Wyncoll, et al.
Open Forum Infectious Diseases|December 21, 2019
Carbapenem Treatment and Outcomes Among Patients With Culture-Positive Complicated Intra-abdominal Infections in US Hospitals: A Retrospective Cohort StudyMarya D Zilberberg, Brian H Nathanson, Kristen Ditch, et al.
Respiratory Medicine|May 30, 2006
Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patientsAndrew F Shorr, Mohammed M Khashab, Jim X Xiang, et al.
Pageof 26